APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Immune Globulin Intravenous

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Immune Globulin Intravenous Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchHuman Immune Globulin Intravenous Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Immune Globulin Intravenous Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Human Immune Globulin Intravenous Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Immune Globulin Intravenous Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Immune Globulin Intravenous Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Human Immune Globulin Intravenous market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Immune Globulin Intravenous is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Immune Globulin Intravenous is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Immune Globulin Intravenous is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Immune Globulin Intravenous is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Immune Globulin Intravenous include Takeda, Sichuan Yuanda Shuyang, Shanghai RAAS, Hualan Bio, Octapharma, LFB Group, Kedrion, Grifols and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Immune Globulin Intravenous, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Immune Globulin Intravenous, also provides the sales of main regions and countries. Of the upcoming market potential for Human Immune Globulin Intravenous, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Immune Globulin Intravenous sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Immune Globulin Intravenous market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Immune Globulin Intravenous sales, projected growth trends, production technology, application and end-user industry.

Human Immune Globulin Intravenous Segment by Company

Takeda

Sichuan Yuanda Shuyang

Shanghai RAAS

Hualan Bio

Octapharma

LFB Group

Kedrion

Grifols

CSL

CNBG

CBPO

BPL

Biotest

Human Immune Globulin Intravenous Segment by Type

IVIg Liquid

IVIg Powder

Human Immune Globulin Intravenous Segment by Application

Autoimmune Disease

Immunodeficiency

Acute Infection

Human Immune Globulin Intravenous Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Immune Globulin Intravenous market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Immune Globulin Intravenous and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Immune Globulin Intravenous.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Immune Globulin Intravenous in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Immune Globulin Intravenous manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Immune Globulin Intravenous sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Immune Globulin Intravenous Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. IVIg Liquid Major Manufacturers Table 3. IVIg Powder Major Manufacturers Table 4. Global Human Immune Globulin Intravenous Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Autoimmune Disease Major Manufacturers Table 6. Immunodeficiency Major Manufacturers Table 7. Acute Infection Major Manufacturers Table 8. Human Immune Globulin Intravenous Industry Trends Table 9. Human Immune Globulin Intravenous Industry Drivers Table 10. Human Immune Globulin Intravenous Industry Opportunities and Challenges Table 11. Human Immune Globulin Intravenous Industry Restraints Table 12. Global Human Immune Globulin Intravenous Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Human Immune Globulin Intravenous Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Human Immune Globulin Intravenous Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2021-2026) Table 16. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2027-2032) Table 17. Global Human Immune Globulin Intravenous Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 18. Global Human Immune Globulin Intravenous Sales by Region (2021-2026) & (units) Table 19. Global Human Immune Globulin Intravenous Sales by Region (2027-2032) & (units) Table 20. Global Human Immune Globulin Intravenous Sales Market Share by Region (2021-2026) Table 21. Global Human Immune Globulin Intravenous Sales Market Share by Region (2027-2032) Table 22. Global Human Immune Globulin Intravenous Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Human Immune Globulin Intravenous Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2021-2026) Table 26. Global Human Immune Globulin Intravenous Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Human Immune Globulin Intravenous Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Human Immune Globulin Intravenous Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Human Immune Globulin Intravenous Manufacturers, Product Type & Application Table 30. Global Human Immune Globulin Intravenous Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Human Immune Globulin Intravenous by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Human Immune Globulin Intravenous Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2021-2026) Table 37. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2027-2032) Table 38. Global Human Immune Globulin Intravenous Sales by Type 2021 VS 2025 VS 2032 (units) Table 39. Global Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 40. Global Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 41. Global Human Immune Globulin Intravenous Sales Market Share by Type (2021-2026) Table 42. Global Human Immune Globulin Intravenous Sales Market Share by Type (2027-2032) Table 43. Global Human Immune Globulin Intravenous Price by Type (2021-2026) & (US$/unit) Table 44. Global Human Immune Globulin Intravenous Price by Type (2027-2032) & (US$/unit) Table 45. Global Human Immune Globulin Intravenous Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2021-2026) Table 49. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2027-2032) Table 50. Global Human Immune Globulin Intravenous Sales by Application 2021 VS 2025 VS 2032 (units) Table 51. Global Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 52. Global Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 53. Global Human Immune Globulin Intravenous Sales Market Share by Application (2021-2026) Table 54. Global Human Immune Globulin Intravenous Sales Market Share by Application (2027-2032) Table 55. Global Human Immune Globulin Intravenous Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Immune Globulin Intravenous Price by Application (2027-2032) & (US$/unit) Table 57. Takeda Company Information Table 58. Takeda Business Overview Table 59. Takeda Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Takeda Human Immune Globulin Intravenous Product Portfolio Table 61. Takeda Recent Development Table 62. Sichuan Yuanda Shuyang Company Information Table 63. Sichuan Yuanda Shuyang Business Overview Table 64. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Portfolio Table 66. Sichuan Yuanda Shuyang Recent Development Table 67. Shanghai RAAS Company Information Table 68. Shanghai RAAS Business Overview Table 69. Shanghai RAAS Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Shanghai RAAS Human Immune Globulin Intravenous Product Portfolio Table 71. Shanghai RAAS Recent Development Table 72. Hualan Bio Company Information Table 73. Hualan Bio Business Overview Table 74. Hualan Bio Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Hualan Bio Human Immune Globulin Intravenous Product Portfolio Table 76. Hualan Bio Recent Development Table 77. Octapharma Company Information Table 78. Octapharma Business Overview Table 79. Octapharma Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Octapharma Human Immune Globulin Intravenous Product Portfolio Table 81. Octapharma Recent Development Table 82. LFB Group Company Information Table 83. LFB Group Business Overview Table 84. LFB Group Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. LFB Group Human Immune Globulin Intravenous Product Portfolio Table 86. LFB Group Recent Development Table 87. Kedrion Company Information Table 88. Kedrion Business Overview Table 89. Kedrion Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Kedrion Human Immune Globulin Intravenous Product Portfolio Table 91. Kedrion Recent Development Table 92. Grifols Company Information Table 93. Grifols Business Overview Table 94. Grifols Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Grifols Human Immune Globulin Intravenous Product Portfolio Table 96. Grifols Recent Development Table 97. CSL Company Information Table 98. CSL Business Overview Table 99. CSL Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. CSL Human Immune Globulin Intravenous Product Portfolio Table 101. CSL Recent Development Table 102. CNBG Company Information Table 103. CNBG Business Overview Table 104. CNBG Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. CNBG Human Immune Globulin Intravenous Product Portfolio Table 106. CNBG Recent Development Table 107. CBPO Company Information Table 108. CBPO Business Overview Table 109. CBPO Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. CBPO Human Immune Globulin Intravenous Product Portfolio Table 111. CBPO Recent Development Table 112. BPL Company Information Table 113. BPL Business Overview Table 114. BPL Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. BPL Human Immune Globulin Intravenous Product Portfolio Table 116. BPL Recent Development Table 117. Biotest Company Information Table 118. Biotest Business Overview Table 119. Biotest Human Immune Globulin Intravenous Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Biotest Human Immune Globulin Intravenous Product Portfolio Table 121. Biotest Recent Development Table 122. North America Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 125. North America Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 126. North America Human Immune Globulin Intravenous Sales Price by Type (2021-2026) & (US$/unit) Table 127. North America Human Immune Globulin Intravenous Sales Price by Type (2027-2032) & (US$/unit) Table 128. North America Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 131. North America Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 132. North America Human Immune Globulin Intravenous Sales Price by Application (2021-2026) & (US$/unit) Table 133. North America Human Immune Globulin Intravenous Sales Price by Application (2027-2032) & (US$/unit) Table 134. North America Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Human Immune Globulin Intravenous Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032) & (units) Table 138. North America Human Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 139. North America Human Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 140. North America Human Immune Globulin Intravenous Sales Price by Country (2021-2026) & (US$/unit) Table 141. North America Human Immune Globulin Intravenous Sales Price by Country (2027-2032) & (US$/unit) Table 142. United States Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 143. Canada Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 144. Mexico Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 145. Europe Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 148. Europe Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 149. Europe Human Immune Globulin Intravenous Sales Price by Type (2021-2026) & (US$/unit) Table 150. Europe Human Immune Globulin Intravenous Sales Price by Type (2027-2032) & (US$/unit) Table 151. Europe Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 154. Europe Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 155. Europe Human Immune Globulin Intravenous Sales Price by Application (2021-2026) & (US$/unit) Table 156. Europe Human Immune Globulin Intravenous Sales Price by Application (2027-2032) & (US$/unit) Table 157. Europe Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Human Immune Globulin Intravenous Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032) & (units) Table 161. Europe Human Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 162. Europe Human Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 163. Europe Human Immune Globulin Intravenous Sales Price by Country (2021-2026) & (US$/unit) Table 164. Europe Human Immune Globulin Intravenous Sales Price by Country (2027-2032) & (US$/unit) Table 165. Germany Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 166. France Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 167. U.K. Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 168. Italy Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 169. Russia Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 170. Spain Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 173. Sweden Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 174. Poland Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 175. China Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 176. China Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 177. China Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 178. China Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 179. China Human Immune Globulin Intravenous Sales Price by Type (2021-2026) & (US$/unit) Table 180. China Human Immune Globulin Intravenous Sales Price by Type (2027-2032) & (US$/unit) Table 181. China Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 182. China Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 183. China Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 184. China Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 185. China Human Immune Globulin Intravenous Sales Price by Application (2021-2026) & (US$/unit) Table 186. China Human Immune Globulin Intravenous Sales Price by Application (2027-2032) & (US$/unit) Table 187. Asia Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 190. Asia Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 191. Asia Human Immune Globulin Intravenous Sales Price by Type (2021-2026) & (US$/unit) Table 192. Asia Human Immune Globulin Intravenous Sales Price by Type (2027-2032) & (US$/unit) Table 193. Asia Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 196. Asia Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 197. Asia Human Immune Globulin Intravenous Sales Price by Application (2021-2026) & (US$/unit) Table 198. Asia Human Immune Globulin Intravenous Sales Price by Application (2027-2032) & (US$/unit) Table 199. Asia Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Human Immune Globulin Intravenous Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032) & (units) Table 203. Asia Human Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 204. Asia Human Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 205. Asia Human Immune Globulin Intravenous Sales Price by Country (2021-2026) & (US$/unit) Table 206. Asia Human Immune Globulin Intravenous Sales Price by Country (2027-2032) & (US$/unit) Table 207. Japan Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 208. South Korea Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 209. India Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 210. Australia Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Human Immune Globulin Intravenous Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Human Immune Globulin Intravenous Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Human Immune Globulin Intravenous Sales by Type (2021-2026) & (units) Table 216. SAMEA Human Immune Globulin Intravenous Sales by Type (2027-2032) & (units) Table 217. SAMEA Human Immune Globulin Intravenous Sales Price by Type (2021-2026) & (US$/unit) Table 218. SAMEA Human Immune Globulin Intravenous Sales Price by Type (2027-2032) & (US$/unit) Table 219. SAMEA Human Immune Globulin Intravenous Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Human Immune Globulin Intravenous Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Human Immune Globulin Intravenous Sales by Application (2021-2026) & (units) Table 222. SAMEA Human Immune Globulin Intravenous Sales by Application (2027-2032) & (units) Table 223. SAMEA Human Immune Globulin Intravenous Sales Price by Application (2021-2026) & (US$/unit) Table 224. SAMEA Human Immune Globulin Intravenous Sales Price by Application (2027-2032) & (US$/unit) Table 225. SAMEA Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Human Immune Globulin Intravenous Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032) & (units) Table 229. SAMEA Human Immune Globulin Intravenous Sales by Country (2021-2026) & (units) Table 230. SAMEA Human Immune Globulin Intravenous Sales by Country (2027-2032) & (units) Table 231. SAMEA Human Immune Globulin Intravenous Sales Price by Country (2021-2026) & (US$/unit) Table 232. SAMEA Human Immune Globulin Intravenous Sales Price by Country (2027-2032) & (US$/unit) Table 233. Brazil Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 234. Argentina Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 235. Chile Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 236. Colombia Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 237. Peru Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 239. Israel Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 240. UAE Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 241. Turkey Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 242. Iran Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 243. Egypt Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Human Immune Globulin Intravenous Distributors List Table 247. Human Immune Globulin Intravenous Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Human Immune Globulin Intravenous Image Figure 2. Global Human Immune Globulin Intravenous Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Immune Globulin Intravenous Market Size Share 2021 VS 2025 VS 2032 Figure 4. IVIg Liquid Image Figure 5. IVIg Powder Image Figure 6. Global Human Immune Globulin Intravenous Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Immune Globulin Intravenous Market Size Share 2021 VS 2025 VS 2032 Figure 8. Autoimmune Disease Image Figure 9. Immunodeficiency Image Figure 10. Acute Infection Image Figure 11. Global Human Immune Globulin Intravenous Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Human Immune Globulin Intravenous Revenue (2021-2032) & (US$ Million) Figure 13. Global Human Immune Globulin Intravenous Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Human Immune Globulin Intravenous Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Human Immune Globulin Intravenous Revenue Market Share by Region (2021-2032) Figure 16. Global Human Immune Globulin Intravenous Sales (2021-2032) & (units) Figure 17. Global Human Immune Globulin Intravenous Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 18. Global Human Immune Globulin Intravenous Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Human Immune Globulin Intravenous Sales YoY (2021-2032) & (units) Figure 20. Europe Human Immune Globulin Intravenous Sales YoY (2021-2032) & (units) Figure 21. China Human Immune Globulin Intravenous Sales YoY (2021-2032) & (units) Figure 22. Asia (Excluding China) Human Immune Globulin Intravenous Sales YoY (2021-2032) & (units) Figure 23. South America, Middle East and Africa Human Immune Globulin Intravenous Sales YoY (2021-2032) & (units) Figure 24. Global Human Immune Globulin Intravenous Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Human Immune Globulin Intravenous Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Human Immune Globulin Intravenous Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Human Immune Globulin Intravenous Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2021-2032) Figure 30. Global Human Immune Globulin Intravenous Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 31. Global Human Immune Globulin Intravenous Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Human Immune Globulin Intravenous Sales Market Share by Type (2021-2032) Figure 33. Global Human Immune Globulin Intravenous Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Human Immune Globulin Intravenous Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2021-2032) Figure 36. Global Human Immune Globulin Intravenous Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 37. Global Human Immune Globulin Intravenous Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Human Immune Globulin Intravenous Sales Market Share by Application (2021-2032) Figure 39. North America Human Immune Globulin Intravenous Revenue Share by Type (2021-2032) Figure 40. North America Human Immune Globulin Intravenous Sales Share by Type (2021-2032) Figure 41. North America Human Immune Globulin Intravenous Revenue Share by Application (2021-2032) Figure 42. North America Human Immune Globulin Intravenous Sales Share by Application (2021-2032) Figure 43. North America Human Immune Globulin Intravenous Revenue Share by Country (2021-2032) Figure 44. North America Human Immune Globulin Intravenous Sales Share by Country (2021-2032) Figure 45. Europe Human Immune Globulin Intravenous Revenue Share by Type (2021-2032) Figure 46. Europe Human Immune Globulin Intravenous Sales Share by Type (2021-2032) Figure 47. Europe Human Immune Globulin Intravenous Revenue Share by Application (2021-2032) Figure 48. Europe Human Immune Globulin Intravenous Sales Share by Application (2021-2032) Figure 49. Europe Human Immune Globulin Intravenous Revenue Share by Country (2021-2032) Figure 50. Europe Human Immune Globulin Intravenous Sales Share by Country (2021-2032) Figure 51. China Human Immune Globulin Intravenous Revenue Share by Type (2021-2032) Figure 52. China Human Immune Globulin Intravenous Sales Share by Type (2021-2032) Figure 53. China Human Immune Globulin Intravenous Revenue Share by Application (2021-2032) Figure 54. China Human Immune Globulin Intravenous Sales Share by Application (2021-2032) Figure 55. Asia Human Immune Globulin Intravenous Revenue Share by Type (2021-2032) Figure 56. Asia Human Immune Globulin Intravenous Sales Share by Type (2021-2032) Figure 57. Asia Human Immune Globulin Intravenous Revenue Share by Application (2021-2032) Figure 58. Asia Human Immune Globulin Intravenous Sales Share by Application (2021-2032) Figure 59. Asia Human Immune Globulin Intravenous Revenue Share by Country (2021-2032) Figure 60. Asia Human Immune Globulin Intravenous Sales Share by Country (2021-2032) Figure 61. SAMEA Human Immune Globulin Intravenous Revenue Share by Type (2021-2032) Figure 62. SAMEA Human Immune Globulin Intravenous Sales Share by Type (2021-2032) Figure 63. SAMEA Human Immune Globulin Intravenous Revenue Share by Application (2021-2032) Figure 64. SAMEA Human Immune Globulin Intravenous Sales Share by Application (2021-2032) Figure 65. SAMEA Human Immune Globulin Intravenous Revenue Share by Country (2021-2032) Figure 66. SAMEA Human Immune Globulin Intravenous Sales Share by Country (2021-2032) Figure 67. Human Immune Globulin Intravenous Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Human Immune Globulin Intravenous Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • IVIg Liquid
  • IVIg Powder
Applications
  • Autoimmune Disease
  • Immunodeficiency
  • Acute Infection
Companies covered
  • Takeda
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Hualan Bio
  • Octapharma
  • LFB Group
  • Kedrion
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Immune Globulin Intravenous Market by Type
  3. 1.2.1 Global Human Immune Globulin Intravenous Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 IVIg Liquid
  5. 1.2.3 IVIg Powder
  6. 1.3 Human Immune Globulin Intravenous Market by Application
  7. 1.3.1 Global Human Immune Globulin Intravenous Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Autoimmune Disease
  9. 1.3.3 Immunodeficiency
  10. 1.3.4 Acute Infection
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Human Immune Globulin Intravenous Market Dynamics
  1. 2.1 Human Immune Globulin Intravenous Industry Trends
  2. 2.2 Human Immune Globulin Intravenous Industry Drivers
  3. 2.3 Human Immune Globulin Intravenous Industry Opportunities and Challenges
  4. 2.4 Human Immune Globulin Intravenous Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Immune Globulin Intravenous Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Immune Globulin Intravenous Revenue by Region
  3. 3.2.1 Global Human Immune Globulin Intravenous Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Immune Globulin Intravenous Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Immune Globulin Intravenous Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Immune Globulin Intravenous Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Immune Globulin Intravenous Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Immune Globulin Intravenous Sales by Region
  9. 3.4.1 Global Human Immune Globulin Intravenous Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Immune Globulin Intravenous Sales by Region (2021-2026)
  11. 3.4.3 Global Human Immune Globulin Intravenous Sales by Region (2027-2032)
  12. 3.4.4 Global Human Immune Globulin Intravenous Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Immune Globulin Intravenous Revenue by Manufacturers
  2. 4.1.1 Global Human Immune Globulin Intravenous Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Immune Globulin Intravenous Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Immune Globulin Intravenous Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Immune Globulin Intravenous Sales by Manufacturers
  6. 4.2.1 Global Human Immune Globulin Intravenous Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Immune Globulin Intravenous Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Immune Globulin Intravenous Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Immune Globulin Intravenous Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Immune Globulin Intravenous Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Immune Globulin Intravenous Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Immune Globulin Intravenous Manufacturers, Product Type & Application
  13. 4.7 Global Human Immune Globulin Intravenous Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Immune Globulin Intravenous Market CR5 and HHI
  16. 4.8.2 2025 Human Immune Globulin Intravenous Tier 1, Tier 2, and Tier 3
5 Human Immune Globulin Intravenous Market by Type
  1. 5.1 Global Human Immune Globulin Intravenous Revenue by Type
  2. 5.1.1 Global Human Immune Globulin Intravenous Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Immune Globulin Intravenous Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Immune Globulin Intravenous Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Immune Globulin Intravenous Sales by Type
  6. 5.2.1 Global Human Immune Globulin Intravenous Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Immune Globulin Intravenous Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Human Immune Globulin Intravenous Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Immune Globulin Intravenous Price by Type
6 Human Immune Globulin Intravenous Market by Application
  1. 6.1 Global Human Immune Globulin Intravenous Revenue by Application
  2. 6.1.1 Global Human Immune Globulin Intravenous Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Immune Globulin Intravenous Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Immune Globulin Intravenous Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Immune Globulin Intravenous Sales by Application
  6. 6.2.1 Global Human Immune Globulin Intravenous Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Immune Globulin Intravenous Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Human Immune Globulin Intravenous Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Immune Globulin Intravenous Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Human Immune Globulin Intravenous Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Sichuan Yuanda Shuyang
  8. 7.2.1 Sichuan Yuanda Shuyang Company Information
  9. 7.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 7.2.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Portfolio
  12. 7.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 7.3 Shanghai RAAS
  14. 7.3.1 Shanghai RAAS Company Information
  15. 7.3.2 Shanghai RAAS Business Overview
  16. 7.3.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai RAAS Human Immune Globulin Intravenous Product Portfolio
  18. 7.3.5 Shanghai RAAS Recent Developments
  19. 7.4 Hualan Bio
  20. 7.4.1 Hualan Bio Company Information
  21. 7.4.2 Hualan Bio Business Overview
  22. 7.4.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hualan Bio Human Immune Globulin Intravenous Product Portfolio
  24. 7.4.5 Hualan Bio Recent Developments
  25. 7.5 Octapharma
  26. 7.5.1 Octapharma Company Information
  27. 7.5.2 Octapharma Business Overview
  28. 7.5.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Octapharma Human Immune Globulin Intravenous Product Portfolio
  30. 7.5.5 Octapharma Recent Developments
  31. 7.6 LFB Group
  32. 7.6.1 LFB Group Company Information
  33. 7.6.2 LFB Group Business Overview
  34. 7.6.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 LFB Group Human Immune Globulin Intravenous Product Portfolio
  36. 7.6.5 LFB Group Recent Developments
  37. 7.7 Kedrion
  38. 7.7.1 Kedrion Company Information
  39. 7.7.2 Kedrion Business Overview
  40. 7.7.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Kedrion Human Immune Globulin Intravenous Product Portfolio
  42. 7.7.5 Kedrion Recent Developments
  43. 7.8 Grifols
  44. 7.8.1 Grifols Company Information
  45. 7.8.2 Grifols Business Overview
  46. 7.8.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Grifols Human Immune Globulin Intravenous Product Portfolio
  48. 7.8.5 Grifols Recent Developments
  49. 7.9 CSL
  50. 7.9.1 CSL Company Information
  51. 7.9.2 CSL Business Overview
  52. 7.9.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CSL Human Immune Globulin Intravenous Product Portfolio
  54. 7.9.5 CSL Recent Developments
  55. 7.10 CNBG
  56. 7.10.1 CNBG Company Information
  57. 7.10.2 CNBG Business Overview
  58. 7.10.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 CNBG Human Immune Globulin Intravenous Product Portfolio
  60. 7.10.5 CNBG Recent Developments
  61. 7.11 CBPO
  62. 7.11.1 CBPO Company Information
  63. 7.11.2 CBPO Business Overview
  64. 7.11.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 CBPO Human Immune Globulin Intravenous Product Portfolio
  66. 7.11.5 CBPO Recent Developments
  67. 7.12 BPL
  68. 7.12.1 BPL Company Information
  69. 7.12.2 BPL Business Overview
  70. 7.12.3 BPL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 BPL Human Immune Globulin Intravenous Product Portfolio
  72. 7.12.5 BPL Recent Developments
  73. 7.13 Biotest
  74. 7.13.1 Biotest Company Information
  75. 7.13.2 Biotest Business Overview
  76. 7.13.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Biotest Human Immune Globulin Intravenous Product Portfolio
  78. 7.13.5 Biotest Recent Developments
8 North America
  1. 8.1 North America Human Immune Globulin Intravenous Market Size by Type
  2. 8.1.1 North America Human Immune Globulin Intravenous Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Immune Globulin Intravenous Sales by Type (2021-2032)
  4. 8.1.3 North America Human Immune Globulin Intravenous Price by Type (2021-2032)
  5. 8.2 North America Human Immune Globulin Intravenous Market Size by Application
  6. 8.2.1 North America Human Immune Globulin Intravenous Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 8.2.3 North America Human Immune Globulin Intravenous Price by Application (2021-2032)
  9. 8.3 North America Human Immune Globulin Intravenous Market Size by Country
  10. 8.3.1 North America Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Immune Globulin Intravenous Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Immune Globulin Intravenous Market Size by Type
  2. 9.1.1 Europe Human Immune Globulin Intravenous Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Immune Globulin Intravenous Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Immune Globulin Intravenous Price by Type (2021-2032)
  5. 9.2 Europe Human Immune Globulin Intravenous Market Size by Application
  6. 9.2.1 Europe Human Immune Globulin Intravenous Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Immune Globulin Intravenous Price by Application (2021-2032)
  9. 9.3 Europe Human Immune Globulin Intravenous Market Size by Country
  10. 9.3.1 Europe Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Immune Globulin Intravenous Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Immune Globulin Intravenous Market Size by Type
  2. 10.1.1 China Human Immune Globulin Intravenous Revenue by Type (2021-2032)
  3. 10.1.2 China Human Immune Globulin Intravenous Sales by Type (2021-2032)
  4. 10.1.3 China Human Immune Globulin Intravenous Price by Type (2021-2032)
  5. 10.2 China Human Immune Globulin Intravenous Market Size by Application
  6. 10.2.1 China Human Immune Globulin Intravenous Revenue by Application (2021-2032)
  7. 10.2.2 China Human Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 10.2.3 China Human Immune Globulin Intravenous Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Immune Globulin Intravenous Market Size by Type
  2. 11.1.1 Asia Human Immune Globulin Intravenous Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Immune Globulin Intravenous Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Immune Globulin Intravenous Price by Type (2021-2032)
  5. 11.2 Asia Human Immune Globulin Intravenous Market Size by Application
  6. 11.2.1 Asia Human Immune Globulin Intravenous Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Immune Globulin Intravenous Price by Application (2021-2032)
  9. 11.3 Asia Human Immune Globulin Intravenous Market Size by Country
  10. 11.3.1 Asia Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Immune Globulin Intravenous Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Immune Globulin Intravenous Market Size by Type
  2. 12.1.1 SAMEA Human Immune Globulin Intravenous Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Immune Globulin Intravenous Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Immune Globulin Intravenous Price by Type (2021-2032)
  5. 12.2 SAMEA Human Immune Globulin Intravenous Market Size by Application
  6. 12.2.1 SAMEA Human Immune Globulin Intravenous Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Immune Globulin Intravenous Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Immune Globulin Intravenous Price by Application (2021-2032)
  9. 12.3 SAMEA Human Immune Globulin Intravenous Market Size by Country
  10. 12.3.1 SAMEA Human Immune Globulin Intravenous Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Immune Globulin Intravenous Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Immune Globulin Intravenous Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Immune Globulin Intravenous Value Chain Analysis
  2. 13.1.1 Human Immune Globulin Intravenous Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Immune Globulin Intravenous Production Mode & Process
  6. 13.2 Human Immune Globulin Intravenous Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Immune Globulin Intravenous Distributors
  9. 13.2.3 Human Immune Globulin Intravenous Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst